Communication
Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol
Article first published online: 5 MAR 2009
DOI: 10.1002/cmdc.200800442
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Bisogno, T., Burston, James J., Rai, R., Allarà, M., Saha, B., Mahadevan, A., Razdan, Raj K., Wiley, Jenny L. and Di Marzo, V. (2009), Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol. ChemMedChem, 4: 946–950. doi: 10.1002/cmdc.200800442
Publication History
- Issue published online: 28 MAY 2009
- Article first published online: 5 MAR 2009
- Manuscript Revised: 3 FEB 2009
- Manuscript Received: 18 DEC 2008
Funded by
- National Institutes of Health. Grant Numbers: DA-09789, DA-03672, DA 008904, DA-05488
- Abstract
- Article
- References
- Cited By
Keywords:
- biosynthesis;
- CB1;
- DAGL;
- endocannabinoids;
- cannabinoids;
- receptors
Abstract

Biosynthesis Inhibition: O-5596, a new inhibitor of the biosynthesis of the endocannabinoid, 2-arachidonoylglycerol, was synthesized and found to be potent (IC50=100 nM) and selective versus other proteins and enzymes of the endocannabinoid system in vitro and active in vivo at reducing food intake in mice.

1860-7187/asset/2452_left.gif?v=1&s=4110e7425ac5e40773dfb0778cfefa62f1594507)
1860-7187/asset/2452_right.gif?v=1&s=8458ea1f15af84217b579501ed7d7733bef04a94)
